CCL4 and metabolic syndrome: In this study, we revealed for the first time that direct inhibition of CCL4 could reverse the impaired insulin signaling pathway by decreasing the phosphorylation of IRS-1 in skeletal muscle and liver tissues in mice with both type 2 DM and metabolic syndrome.